Figure 1From: Trace element supplementation in hemodialysis patients: a randomized controlled trialParticipant flow diagram. All participants who received at least one dose of the trial intervention were included in the intention-to-treat primary analysis (51 in the medium dose group, 47 in the low dose group, and 49 in the standard dose group). *Participants may have more than one reason for ineligibility.Back to article page